Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Zepzelca

PharmaCompass

01

Brand Name : Zepzelca

Lurbinectedin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Zepzelca

arrow
Antibody Engineering
Not Confirmed

Lurbinectedin

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 90

2019 Revenue in Millions : 0

Growth (%) : New Launch

blank

02

Brand Name : Zepzelca

Lurbinectedin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Zepzelca

arrow
Antibody Engineering
Not Confirmed

Lurbinectedin

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 247

2020 Revenue in Millions : 90

Growth (%) : 173

blank

03

Brand Name : Zepzelca

Lurbinectedin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Zepzelca

arrow
Antibody Engineering
Not Confirmed

Lurbinectedin

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 270

2021 Revenue in Millions : 247

Growth (%) : 9

blank

04

Brand Name : Zepzelca

Lurbinectedin

arrow
Antibody Engineering
Not Confirmed

Brand Name : Zepzelca

arrow
Antibody Engineering
Not Confirmed

Lurbinectedin

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 290

2022 Revenue in Millions : 270

Growth (%) : 7

blank